Get the Stockscreener App
85.27
0.58%
-0.50
After Hours:
85.27
Solventum Corp stock is traded at $85.27, with a volume of 988.02K.
It is down -0.58% in the last 24 hours and up +19.36% over the past month.
In spring 2024, 3M spun out its legacy healthcare segment as a stand-alone firm, Solventum. At that time, the firm comprised four segments. The smallest one—purification and filtration—has since been sold. Now, medsurg is the largest business, contributing roughly 64% of consolidated revenue, and includes advanced wound care and wound prevention. Dental solutions (restorative composites and orthodontia) and health information systems (mainly revenue cycle management) each contribute 18% of total revenue.
See More
Previous Close:
$85.77
Open:
$85.77
24h Volume:
988.02K
Relative Volume:
0.92
Market Cap:
$14.79B
Revenue:
$8.31B
Net Income/Loss:
$379.00M
P/E Ratio:
39.48
EPS:
2.16
Net Cash Flow:
$385.00M
1W Performance:
+10.30%
1M Performance:
+19.36%
6M Performance:
+20.42%
1Y Performance:
+19.28%
1-Day Range:
$85.25
$86.81
1-Week Range:
$78.00
$86.81
52-Week Range:
$60.70
$86.81
Solventum Corp Stock (SOLV) Company Profile
Name
Solventum Corp
Sector
Industry
Phone
651-733-1110
Address
C/O 3M COMPANY, ST. PAUL
Compare SOLV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
85.27 | 14.88B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
574.23 | 205.21B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.90 | 56.03B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
79.17 | 39.13B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
255.04 | 37.34B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
277.14 | 20.20B | 2.96B | 487.70M | 344.00M | 6.6758 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-25 | Initiated | UBS | Neutral |
| Sep-11-25 | Initiated | Jefferies | Hold |
| Jul-15-25 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jul-01-25 | Upgrade | Argus | Hold → Buy |
| Jun-06-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| May-19-25 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Oct-08-24 | Initiated | Stifel | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Neutral |
| Sep-26-24 | Initiated | Wolfe Research | Peer Perform |
| Sep-05-24 | Initiated | BTIG Research | Neutral |
| Jun-24-24 | Initiated | Argus | Hold |
| May-30-24 | Initiated | Goldman | Sell |
| May-10-24 | Initiated | BofA Securities | Neutral |
| Apr-10-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-08-24 | Initiated | Wells Fargo | Equal Weight |
| Apr-02-24 | Initiated | Edward Jones | Hold |
View All
Solventum Corp Stock (SOLV) Latest News
The Beat: ShopFloor Coffee eyes Walmart; Apasa Foods strategy, Solventum deal - The Business Journals
Is Solventum’s (SOLV) Billion-Dollar Buyback a Signal of Strength or Strategic Caution? - simplywall.st
Solventum's second-quarter profit falls 70% on higher expenses - AOL.com
Solventum Corp (1SOLV.MI) Stock Major Holders - Yahoo! Finance Canada
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference - Eastern Progress
9-Day Rally Sends Solventum Stock Up 16% - Trefis
Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference – Company Announcement - Financial Times
Solventum Corp stock hits 52-week high at 85.92 USD By Investing.com - Investing.com South Africa
Model ML raises again, gene-editing gains backers and Solventum's wound care buy - Axios
Solventum to buy private wound care firm Acera for up to $850M - MSN
Solventum Stock Surges 13%, With A 8-Day Winning Spree - Trefis
Solventum to acquire Acera Surgical in $725 million deal - Indian Pharma Post
Solventum (SOLV): Assessing Valuation After $1 Billion Share Buyback Announcement - Yahoo Finance
Solventum Seeks to Chart Its Own Path, Improve Operations, and Raise Profitability - Morningstar
Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - Yahoo Finance
Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock - Fierce Biotech
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Stocks Flashing Renewed Technical Strength: Solventum - Investor's Business Daily
Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha
Solventum sets $1 billion share repurchase program - MSN
Quick ratio of Solventum Corporation – HAM:KB7 - TradingView
Solventum To Buy Acera Surgical In $850 Million Deal To Expand Advanced Wound Care Portfolio - Pulse 2.0
Solventum stock rating reiterated by UBS, Acera deal fills wound care gap - Investing.com South Africa
Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Finviz
Solventum Corporation Reports Strong Q3 2025 Results - MSN
Solventum Stock Gets Relative Strength Rating Lift - Investor's Business Daily
A Look at Solventum’s Valuation Following $1 Billion Share Buyback Authorization - simplywall.st
Acera Surgical, born from WashU research, to be acquired for up to $850M - The Business Journals
Agree To Buy Solventum At $70, Earn 6.6% Annualized Using Options - Nasdaq
Solventum inks $725M Acera takeover - MedTech Dive
Solventum Trying To Close In On Key Technical Measure - MSN
Solventum stock rating reiterated by UBS, Acera deal fills wound care gap By Investing.com - Investing.com Nigeria
Solventum agrees to buy regenerative wound care maker Acera Surgical for $725M+ - The Business Journals
How institutional buying supports Solventum Corporation stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges - TipRanks
Solventum to acquire Acera Surgical - Medical Buyer
How Solventum Corporation stock behaves in tightening cyclesBear Alert & AI Powered Buy and Sell Recommendations - newser.com
Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential - TipRanks
Solventum announces $1 billion share repurchase program By Investing.com - Investing.com Nigeria
Solventum to acquire Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Corp. stock rises Thursday, outperforms market - MarketWatch
Solventum stock rises on $1 billion share buyback, Acera acquisition By Investing.com - Investing.com Nigeria
Solventum stock rises on $1 billion share buyback, Acera acquisition - Investing.com
Solventum to Acquire Acera Surgical for $850M - Medical Device and Diagnostic industry
Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares - MassDevice
Solventum Corporation entered into a definitive agreement to acquire Acera Surgical, Inc. for $850 million. - MarketScreener
Solventum agrees to acquire Acera for up to $850M - BioWorld MedTech
Solventum Corp Stock (SOLV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):